Mesenchymal Stem Cells Improve Medullary Inflammation and Fibrosis after Revascularization of Swine Atherosclerotic Renal Artery Stenosis

• Behzad Ebrahimi,

  Affiliation Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Alfonso Eirin,

  Affiliation Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Zilun Li,

  Affiliations Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, United States of America, Division of Vascular Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

  ⨯
• Xiang-Yang Zhu,

  Affiliation Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Xin Zhang,

  Affiliation Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Amir Lerman,

  Affiliation Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Stephen C. Textor,

  Affiliation Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Lilach O. Lerman

  * E-mail: lerman.lilach@mayo.edu

  Affiliation Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯